Citation Impact
Citing Papers
Endocrine Disruptors and Asthma-Associated Chemicals in Consumer Products
2012 Standout
Dose optimization in HDR brachytherapy: A literature review of quantitative models
2011
MiRP1 Forms IKr Potassium Channels with HERG and Is Associated with Cardiac Arrhythmia
1999 Standout
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
2006
Venlafaxine Extended-Release
2001
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
2010 Standout
Engineering precision nanoparticles for drug delivery
2020 Standout
MR‐guided prostate interventions
2008
Image-guided radiotherapy: from current concept to future perspectives
2012
Polymorphism of human cytochrome P450 enzymes and its clinical impact
2009
Genetic variability of drug-metabolizing enzymes: the dual impact on psychiatric therapy and regulation of brain function
2012
Network pharmacology: the next paradigm in drug discovery
2008 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
A randomized, double-blind, placebo-controlled trial of a chemokine receptor 2 (CCR2) antagonist in posttraumatic neuralgia
2013
Pharmacologic management of neuropathic pain: Evidence-based recommendations
2007 Standout
3D Slicer as an image computing platform for the Quantitative Imaging Network
2012 Standout
CYP2D6 and CYP2C19 genotype‐based dose recommendations for antidepressants:
a first step towards subpopulation‐specific dosages
2001
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development
2003
Chiral signature of venlafaxine as a marker of biological attenuation processes
2012
Modulating the antibody density changes the uptake and transport at the blood-brain barrier of both transferrin receptor-targeted gold nanoparticles and liposomal cargo
2019
Metabolism of Antidepressant and Neuroleptic Drugs by Cytochrome P450s: Clinical and Interethnic Aspects
2007
Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response
2004
Task Force on Sudden Cardiac Death of the European Society of Cardiology
2001
Assessment of the stereoselective metabolism of methaqualone in man by capillary electrophoresis
2003
A constitutively open potassium channel formed by KCNQ1 and KCNE3
2000 StandoutNature
A review on emerging contaminants in wastewaters and the environment: Current knowledge, understudied areas and recommendations for future monitoring
2014 Standout
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
2013 Standout
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
β-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO)
2009 Standout
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)
2005 Standout
Antibacterial macrolides: a drug class with a complex pharmacological profile
2004
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Chiral Toxicology: It's the Same Thing…Only Different
2009
Torsade de Pointes with an antihistamine metabolite: Potassium channel blockade with desmethylastemizole
1996
Clinically Significant Drug Interactions with Newer Antidepressants
2011
Pharmacogenetics and adverse drug reactions
2000
2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis
2016 Standout
A Novel Approach to Predicting P450 Mediated Drug Metabolism. CYP2D6 Catalyzed N-Dealkylation Reactions and Qualitative Metabolite Predictions Using a Combined Protein and Pharmacophore Model for CYP2D6
1999
Simulated Annealing
2012
Operating room planning and scheduling: A literature review
2009 Standout
Metaheuristics in Combinatorial Optimization
2005 Standout
Pharmacological interventions for somatoform disorders in adults
2014 Standout
The General Utility Lattice Program (GULP )
2003 Standout
Docking and scoring in virtual screening for drug discovery: methods and applications
2004 Standout
Quantum-information processing with circuit quantum electrodynamics
2007 StandoutNobel
Chernobyl-Related Thyroid Cancer in Children of Belarus: A Case-Control Study
1998 Standout
Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture
2011 StandoutNobel
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
A comprehensive review of firefly algorithms
2013 Standout
Enantiomeric Profiling of Chiral Drugs in Wastewater and Receiving Waters
2011
Venlafaxine versus imipramine in painful polyneuropathy
2003
Pharmacogenetic testing among patients with mood and anxiety disorders is associated with decreased utilization and cost: A propensity-score matched study
2018 StandoutNobel
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Temporomandibular Disorders
2008 Standout
Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods
2019 Standout
Assessing Atropisomer Axial Chirality in Drug Discovery and Development
2011 Standout
Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder
2008 Standout
Issues and Epidemiological Evidence regarding Radiation-Induced Thyroid Cancer
1992
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
2016 Standout
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
1999 StandoutScience
Coprescription of Tamoxifen and Medications That Inhibit CYP2D6
2010
2003
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Works of Étienne Lessard being referenced
Inverse planning anatomy‐based dose optimization for HDR‐brachytherapy of the prostate using fast simulated annealing algorithm and dedicated objective function
2001
Inverse planning simulated annealing for magnetic resonance imaging-based intracavitary high-dose-rate brachytherapy for cervical cancer
2008
Inverse planning for interstitial gynecologic template brachytherapy: truly anatomy-based planning
2002
Role of specific cytochrome P450 enzymes in the N-oxidation of the antiarrhythmic agent mexiletine
2003
MRI-guided HDR prostate brachytherapy in standard 1.5T scanner
2004
Class solution in inverse planned HDR prostate brachytherapy for dose escalation of DIL defined by combined MRI/MRSI
2008
Early clinical experience with anatomy-based inverse planning dose optimization for high-dose-rate boost of the prostate
2002
Role of CYP2D6 in the N-hydroxylation of procainamide
1997
Inverse planning for HDR prostate brachytherapy used to boost dominant intraprostatic lesions defined by magnetic resonance spectroscopy imaging
2004
Optimization of HDR brachytherapy dose distributions using linear programming with penalty costs
2006
Inverse treatment planning based on MRI for HDR prostate brachytherapy
2005
Diphenhydramine Alters the Disposition of Venlafaxine Through Inhibition of CYP2D6 Activity in Humans
2001
Optimization of dose distribution for HDR brachytherapy of the prostate using Attraction-Repulsion Model
2005
Anatomy-based inverse planning dose optimization in HDR prostate implant: A toxicity study
2005
Involvement of CYP2D6 activity in the N-oxidation of procainamide in man
1999
Role of CYP2D6 in the stereoselective disposition of venlafaxine in humans.
2003
3D inverse treatment planning for the tandem and ovoid applicator in cervical cancer
2005
Influence of CYP2D6 activity on the disposition and cardiovascular toxicity of the antidepressant agent venlafaxine in humans.
1999
Enhanced Delivery of Galanin Conjugates to the Brain through Bioengineering of the Anti-Transferrin Receptor Antibody OX26
2018
SU‐FF‐T‐337: Multiobjective Inverse Planning Optimization: Adjustment of Dose Homogeneity and Urethra Protection in HDR‐Brachytherapy of the Prostate
2006
Blocking Spinal CCR2 with AZ889 Reversed Hyperalgesia in a Model of Neuropathic Pain
2010
Development and clinical introduction of an inverse planning dose optimization by simulated annealing (IPSA) for high dose rate brachytherapy
2004
Thyroid cancer in the Marshallese: relative risk of short-lived internal emitters and external radiation exposure
1985
Venlafaxine-diphenhydramine interaction in subjects with extensive or poor CYP2D6 activity
1999
Erythromycin Blocks the Rapid Component of the Delayed Rectifier Potassium Current and Lengthens Repolarization of Guinea Pig Ventricular Myocytes
1995